The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a study designed to determine whether certain approved therapies or investigational […]
The importance of diversity of patients in clinical studies cannot be overlooked, nor can the importance of diversity at the C-suite level. But, it’s equally important to have a diverse clinical research team as […]
We applaud the Sept. 2 op-ed by Rep. Karen Bass (D-Calif.) regarding the importance of promoting diversity in the clinical trial patient population [“Vaccine trials’ lack of diversity threatens their […]
Current and prospective clinical trial practitioners sell themselves and the future of the industry short if they view technology as a threat and not an opportunity, says long-time clinical trial […]
Increasing use of technology and broader adoption of decentralized clinical trials (DCTs) will require an unprecedented transformation of the clinical research workforce. That’s the conclusion of a new white paper […]